ArticleJournal of exposure science & environmental epidemiology2026
Metabolome-wide association study identifies metabolites associated with human exposure to perfluoroalkyl substances.
Article in Journal of exposure science & environmental epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerfluoroalkyl substances (PFAS) are organic compounds with widespread environmental occurrence and documented associations with multiple health effects. The pathophysiology remains unclear, although there are indications of potential involvement of metabolic pathways.
objectiveTo evaluate associations between serum PFAS concentrations and the metabolome in Swedish adults.
methodsWe conducted an extensive metabolome-wide association analysis (MWAS) to explore the potential links between serum metabolites and serum concentrations of PFOS, PFOA, and PFHxS in a cohort comprising 2353 participants from the EpiHealth study. Liquid chromatography coupled with mass spectrometry was used to obtain levels of PFAS and 790 distinct non-xenobiotic metabolites. Results were validated in 1104 participants from the POEM and PIVUS cohort. Linear regression models were adjusted for age, sex, BMI, smoking, exercise, education, and diabetes.
results236 metabolites were validated to be significantly associated with PFOS, and 190 metabolites associated with PFOA using FDR < 0.05. No significant associations could be validated for PFHxS. The metabolites showing the strongest associations with both PFOS and PFOA were various lipid-related metabolites, including long-chain polyunsaturated fatty acids (n3 and n6), saturated fatty acids, and monounsaturated fatty acids. Also, lysophospholipids, sphingomyelins, phosphatidylcholines, as well as various amino acids, were related to the two PFAS. Metabolic pathway analysis identified significant enrichment of metabolites involved in branched-chain amino acid biosynthesis, synthesis of unsaturated fatty acids, and arginine biosynthesis. IMPACT STATEMENT: This study provides a large-scale, externally validated map of metabolites associated with background human exposure to major PFAS. In a population-based metabolome-wide association study (MWAS) with independent validation, PFOS and PFOA showed robust associations with lipid classes and amino acids, whereas no associations were validated for PFHxS. These findings strengthen biological plausibility for PFAS-health associations and prioritize metabolic pathways for future mechanistic and environmental epidemiology studies.
Indexed as
Identifiers
42337364What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.